{"name":"Vyome Therapeutics Inc.","slug":"vyome-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOb01ITmJDUWduSGI1WGlaOTJKNDNHNlRzOFZkVGphU0VBTi05dGthTGJoRXhBdHBNTi1rZUlEZWRVV2JKZ0ZZUnVzVjBXdndmRXV2RWdaXzhfMDBRclZNYm1XV1Z3eF9VbldFNnZYdVRPbzlMWUtpLS1XMFdHdTV6NldCMGpvbFM5YVFlQkFyUklWR3Jad0tvUjhNS0V6MThYc29faWF1RDVqMlNjbUI2MHNpU0ZQNVU?oc=5","date":"2026-01-05","type":"regulatory","source":"Drug Discovery News","summary":"Experimental gel could become the first approved treatment for cancer wounds - Drug Discovery News","headline":"Experimental gel could become the first approved treatment for cancer wounds","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE14NFpjRG9NUExsR1BRR2JoaUpTLUcwTFRhcHlCbFc4NTcyeF9QNzQ1c1BrZWxWTDVuU0lUQkpRakYwY2IxOVR3UExMLUsxa1Q0b3VGbUtuRmdKeFhp?oc=5","date":"2025-12-05","type":"pipeline","source":"TradingView","summary":"HIND Stock Price and Chart — NASDAQ:HIND - TradingView","headline":"HIND Stock Price and Chart — NASDAQ:HIND","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE10NktOS2M1TGUxLW1JZGluNnQ1UC11Z2ZFc3BpNk9mS2hBemdnRnppUG1nSE94LTZBS2xGNkdTTTBwN0tzUWpQYnFpUWZVYWNva29kU0xuU3lBZXBzdGY0?oc=5","date":"2025-10-11","type":"pipeline","source":"ChartMill","summary":"HIND Stock Price, Quote & Chart | VYOME HOLDINGS INC (NASDAQ:HIND) - ChartMill","headline":"HIND Stock Price, Quote & Chart | VYOME HOLDINGS INC (NASDAQ:HIND)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPd2ZrYkc4aHhiVXRBalJqVlpHU0hlVExHcXR5a001VC1ZUVZBeWdiWkp4Tl9IUE9sQzVJTk9XemxRclJSeERrUGRuUTAzck02SFRIWHpCYXN4SVRPX0NQSVBqWWY3b3cyNDZYTHdPNVBFSHBmNk4yMVVobW9VTkswMkpFUHB1U3BWR1JNUXM3Y3ZRUlN2Qjg0alJjakV2UmtjYmk0RzdHSUdoQ21CSFBNOWF0cDJtbW93eGRmQjNuN1BYS3ZxQTRjNG5Ub3pUX0lRSU5rc1Q2VUwtRExzdDVxc3RTSjl0eEtwcnRWQw?oc=5","date":"2025-09-09","type":"trial","source":"Business Wire","summary":"Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies - Business Wire","headline":"Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPb29GaW02by0zakNkQm1NNXBLQUZYT0RfMTViODdISkNLQTFfWF9hV19GMEs2djkzYXFNb05IWS13bzV6OExvSnJSbUhfWFpKYWloVjhHMzV0WGtKSXJTRDZjcmxZallaYnZOUzMxZjFEQ0hfRmpjLVdyQXl1NEI5MEpVUQ?oc=5","date":"2025-08-25","type":"pipeline","source":"Pharmaceutical Executive","summary":"Insights from Vyome on Building a Global Biotech Network - Pharmaceutical Executive","headline":"Insights from Vyome on Building a Global Biotech Network","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPZ3FSaWNUc08yYmFjdHdSRkFYWmJkRlo3UjZiQlctV1VHTnFjWUNqbnZCek5Sa3AtNjB6ZEUxZ0VFUVBMakowVk5UekhjZzFSMU5hYk5HeHRab0FRM1pwTWU0Sng5Rmx4N3JfTzJtcFVPaHdRUnpHc2d4d3d4cmdQTURRbmZLdDM5emRPR0RWUQ?oc=5","date":"2025-08-22","type":"deal","source":"Pharmaceutical Executive","summary":"Reverse Merger Offers Vyome Cost Effective Route to Go Public - Pharmaceutical Executive","headline":"Reverse Merger Offers Vyome Cost Effective Route to Go Public","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPaXdhTEhGbFZZdFFuNXE3Szk4eGlLRHhSa1NkZG1ma3JvN0cyMkswbm9ZSFUzRHJzX0prQ1AtaHM3bzhHZENEeU9VUWRMazVWWHE2UHh0QVpvUGYxekxTclBNbnlLa3FtY3lVckdkbHEzcFBLRVB2UHg5MUJ6TTcyMWtrSXozN044SkE?oc=5","date":"2025-08-17","type":"pipeline","source":"YourStory.com","summary":"Vyome Debuts as HIND on Nasdaq, Strengthening US-India Innovation Ties - YourStory.com","headline":"Vyome Debuts as HIND on Nasdaq, Strengthening US-India Innovation Ties","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-16","type":"deal","source":"The Times of India","summary":"Vyome lists on Nasdaq as HIND after ReShape merger - The Times of India","headline":"Vyome lists on Nasdaq as HIND after ReShape merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNUkJfZF9Pcy1Fb1VBUEhJQkI1Z3NyVVp2TXJWX0dPMUJVNTc0Y0kwaUNzUEJpOXQ5MWFjc1pXRlozaVo2d3I2cUFLbXMydW8yM3VreEhxZURkMXZXWjhNZmEtQ1ZKQ1M0S1JpaHdtc1NVdWVUeS15VFF4ZGY4WHI1R29n?oc=5","date":"2025-08-12","type":"pipeline","source":"citybiz","summary":"Vyome Appoints New Board of Directors - citybiz","headline":"Vyome Appoints New Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOT1FGZmZiSy1IWEFkZVE3RlRia1F6cVNQMDlzOTk5aXlvN21nWlJrNlMzR05MVEVOUTktTllwaUlMUmM5djJfY09iazhXN1RLak4td1U0SlZVWUZ6bHBvOVJtc0t0dVBIdHlfeTMwVjdEdFpFYWpSWjU3ZkQyazZRNllYeGl1OW1yRVlWVDhDN1RKRENVSk5fcUVwSjJsY1IzNDM2Q19mVHFoU0ZQanNwYnVmU29nV0tlRFp4UndwX0xmdUU?oc=5","date":"2025-08-08","type":"regulatory","source":"BioSpace","summary":"ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics - BioSpace","headline":"ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOTWNLYXBuMXg4elN0YnpxRGNOWXRSYWh1cVFnTkY1dm5BRm1kMnhJc0dTVlFXWjRsSFFON2xwZlJZVHAyLTVoUFBEeTEzcGp1azQtb2M5X202R2hzaVlMWGNFZnNhMTJyejYyaWFRU25LdF9SUDVwN3I3dmdNLXpnMzhwQ1UtNDZEam5QUGtFR21BX2s5TEpsdkRiWjIxSXNxVWc?oc=5","date":"2025-01-13","type":"deal","source":"Investing.com","summary":"ReShape and Vyome to merge in all-stock deal - Investing.com","headline":"ReShape and Vyome to merge in all-stock deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxNdHJOeDdTTXphUk00aGRnaDVsUUNSdHJUT0JyUklKc0JGdEJoazNMZk9Nd2N2ZHAzazNDZjhULXhkUlBWOExURm0xTkpQQnV1eTIzZzRFQnJfYzlabGpWeWpPOHFHRDdXMTBSS2NXQ0xJc09zVUVTQUUxQUg3Qkl2djd0UUR4bGxfZzQ3TlZUelJyNTI3bnNIM2VUTXkyeEh3T2pXd1VGT2ZUa2hRLTJyMThHOVRPS0x5Y3pfZk82bUJyN1JnVlB1V21EeHZCeGhnWDBDOEtfQndKMHdqbjV5UVJHel80dXdFbkNGa1RDRGxpWnZTN3k5N2pSRGFxYl9NeFpQeFhVZTVKM1lnU3AzVGliZlhSY0lONUFHWkg0OA?oc=5","date":"2024-07-09","type":"deal","source":"globenewswire.com","summary":"ReShape Lifesciences® Enters Into Merger Agreement With - globenewswire.com","headline":"ReShape Lifesciences® Enters Into Merger Agreement With","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}